Literature DB >> 20648428

Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.

Damian Pres1, Mariusz Gasior, Krzysztof Strojek, Marek Gierlotka, Michał Hawranek, Andrzej Lekston, Krzysztof Wilczek, Mateusz Tajstra, Janusz Gumprecht, Lech Poloński.   

Abstract

BACKGROUND: It has been shown that hyperglycaemia is associated with increased in-hospital and long-term mortality in patients with myocardial infarction (MI). There are only a few reports on the relationship between glycaemia in the acute phase of MI complicated by cardiogenic shock (CS) and prognosis. AIM: To assess the relationship between blood glucose level on admission and in-hospital as well as long-term mortality in patients with acute ST-segment elevation MI (STEMI) complicated by CS treated with percutaneous coronary intervention (PCI).
METHODS: Consecutive patients with STEMI complicated by CS treated with PCI were included. For the purpose of this analysis, the patients were divided into two groups: the first group included patients with glycaemia on admission < 7.8 mmol/L, and the other group patients with glycaemia > or = 7.8 mmol/L (hyperglycaemia group). Selected parameters from the in-hospital and long-term follow-up were compared between the two groups. Due to a possible linear relationship between blood glucose and mortality in multivariate analysis, glucose level on admission was treated as a continuous variable. The primary outcomes included in-hospital, 1-year and 5-year mortality.
RESULTS: Out of 3166 consecutive patients with STEMI, 258 had CS and available data on glycaemia. In patients with hyperglycaemia on admission, we observed higher in-hospital (41.5% vs 28%, p = 0.041), 1-year (51.4% vs 34.7%, p = 0.015) and 5-year (65.8% vs 43.3%, p = 0.034) mortality in comparison to the patients with blood glucose < 7.8 mmol/L. The multivariate analysis revealed that blood glucose level on admission (per each glycaemia increment by 1 mmol/L) was an independent prognostic factor of in-hospital (OR 1.08, 95% CI 1.02-1.14, p = 0.0044), 1-year (HR 1.04, 95% CI 1.01-1.06, p = 0.005) and 5-year mortality (HR 1.03, 95% CI 1.01-1.05, p = 0.045). Of note, the diagnosis of diabetes mellitus had no influence on in-hospital and long-term mortality.
CONCLUSIONS: Elevated blood glucose level on admission, regardless of the diagnosis of diabetes mellitus, results in increased in-hospital and long-term mortality in patients with STEMI complicated by CS and treated with PCI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20648428

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  8 in total

1.  Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes.

Authors:  Chiara Lazzeri; Serafina Valente; Paola Attanà; Marco Chiostri; Claudio Picariello; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2011-05-05       Impact factor: 3.397

Review 2.  Laboratory Predictors of Prognosis in Cardiogenic Shock Complicating Acute Myocardial Infarction.

Authors:  Tamilla Muzafarova; Zuzana Motovska
Journal:  Biomedicines       Date:  2022-06-05

3.  The classification of hospitalized patients with hyperglycemia and its implication on outcome: results from a prospective observational study in Internal Medicine.

Authors:  Filippo Pieralli; Cristina Bazzini; Alessia Fabbri; Carlotta Casati; Andrea Crociani; Francesco Corradi; Alberto Moggi Pignone; Alessandro Morettini; Carlo Nozzoli
Journal:  Intern Emerg Med       Date:  2015-11-26       Impact factor: 3.397

Review 4.  Hyperglycemia in acute heart failure: an opportunity to intervene?

Authors:  Chiara Lazzeri; Serafina Valente; Gian Franco Gensini
Journal:  Curr Heart Fail Rep       Date:  2014-09

5.  Abnormal glucose regulation in Chinese patients with coronary artery disease: a gender analysis.

Authors:  Juan Liu; Li-Qun He; Wei Zhu; Gang-Feng Duan; Yong Fang; Ying Feng; Li-Qun Tian; Qiong-Li Zheng
Journal:  J Cardiothorac Surg       Date:  2022-05-03       Impact factor: 1.522

6.  Admission hyperglycemia predicts poorer short- and long-term outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction.

Authors:  Pei-Chi Chen; Su-Kiat Chua; Huei-Fong Hung; Chung-Yen Huang; Chiu-Mei Lin; Shih-Ming Lai; Yen-Ling Chen; Jun-Jack Cheng; Chiung-Zuan Chiu; Shih-Huang Lee; Huey-Ming Lo; Kou-Gi Shyu
Journal:  J Diabetes Investig       Date:  2013-06-17       Impact factor: 4.232

7.  Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention.

Authors:  Yuanyuan Hao; Qun Lu; Tao Li; Guodong Yang; Peijing Hu; Aiqun Ma
Journal:  BMC Cardiovasc Disord       Date:  2017-01-05       Impact factor: 2.298

8.  Intervention by clinical pharmacists can improve blood glucose fluctuation in patients with diabetes and acute myocardial infarction: A propensity score-matched analysis.

Authors:  Fang-Hong Shi; Long Shen; Jiang Yue; Jing Ma; Zhi-Chun Gu; Hao Li; Hou-Wen Lin
Journal:  Pharmacol Res Perspect       Date:  2021-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.